Humacyte Analyst Ratings
Humacyte (HUMA) Receives a Buy From Benchmark Co.
Analysts Are Bullish on Top Healthcare Stocks: Humacyte (HUMA), Rallybio (RLYB)
Humacyte Analyst Ratings
Benchmark Co. Keeps Their Buy Rating on Humacyte (HUMA)
Analysts' Top Healthcare Picks: Humacyte (HUMA), Janux Therapeutics Inc (JANX)
Oppenheimer Keeps Their Buy Rating on Humacyte (HUMA)
Humacyte Analyst Ratings
Piper Sandler Sticks to Its Hold Rating for Humacyte (HUMA)
Humacyte Analyst Ratings
Humacyte's Strong Outlook: Buy Rating Affirmed Amid Advancements and Market Opportunity
Buy Rating for Humacyte: Anticipated FDA Approval and Strong Financials Signal Growth Potential
Humacyte Analyst Ratings
Piper Sandler Reaffirms Their Hold Rating on Humacyte (HUMA)
Analysts Offer Insights on Healthcare Companies: Embecta Corporation (EMBC), Mettler-Toledo (MTD) and Humacyte (HUMA)
Buy Rating Justified by FDA Review and Commercial Prospects for Humacyte's HAV Device
Humacyte (HUMA) Gets a Buy From BTIG
Benchmark Maintains Buy on Humacyte, Lowers Price Target to $15
Humacyte Analyst Ratings
Benchmark Co. Sticks to Their Buy Rating for Humacyte (HUMA)
No Data